Literature DB >> 15489215

Quality evaluation of commercial extracts of Scutellaria baicalensis.

Fei Ye1, Hongyan Wang, Shiquan Jiang, Josephine Wu, Jun Shao, Xueren Cheng, Yaosheng Tu, David Y Zhang.   

Abstract

Botanical products have been widely used for various illnesses and general well-being. However, quality control of botanical products is often not performed due to lack of standardization, resulting in inconsistent efficacies and sometimes serious toxicity. The goals of this study were to determine the correlation between chemical composition and biological activities and to establish a method to measure authenticity, chemical consistency, and biological potency of botanical products. A high-performance liquid chromatography method was used to analyze the authenticity and chemical composition of 10 different commercial extracts. The cell viability assay and prostaglandin E2 (PGE2) enzyme immunoassay were used to analyze biological potency and consistency. Our results showed all extracts contained marker components (baicalein and/or baicalin), confirming their authenticity. However, significant product-to-product and batch-to-batch variation of these marker components was observed with 4 products containing no baicalin at all and baicalein concentration ranging from 0 to 52.3 g/mg. The 50% growth inhibition concentration of the extracts ranged from 0.18 to 2.0 mg/ml, more than an 11-fold variation. PGE2 levels varied from 19.5 to 111.1 pg/106 cells, more than a 5.7-fold difference. These results demonstrated significant variation in chemical composition and biological activities of the commercial extracts and that the amount of marker components may not reflect biological activity levels. Therefore, chemical analysis alone is inadequate for quality control, and biological assays must be included for botanical products to ensure chemical authenticity as well as pharmacological/biological potency and consistency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489215     DOI: 10.1207/s15327914nc4902_14

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  7 in total

1.  Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells.

Authors:  Chong-Zhi Wang; Xiao-Li Li; Qian-Fei Wang; Sangeeta R Mehendale; Chun-Su Yuan
Journal:  Phytomedicine       Date:  2010-01       Impact factor: 5.340

2.  DNA microarrays in herbal drug research.

Authors:  Preeti Chavan; Kalpana Joshi; Bhushan Patwardhan
Journal:  Evid Based Complement Alternat Med       Date:  2006-10-27       Impact factor: 2.629

3.  Comparative pharmacokinetics of baicalin, wogonoside, baicalein and wogonin in plasma after oral administration of pure baicalin, radix scutellariae and scutellariae-paeoniae couple extracts in normal and ulcerative colitis rats.

Authors:  Zhen-Qiu Zhang; Wei Liua; Li Zhuang; Jing Wang; Shuai Zhang
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

4.  Therapeutic properties of Scutellaria baicalensis in db/db mice evaluated using Connectivity Map and network pharmacology.

Authors:  Bu-Yeo Kim; Kwang Hoon Song; Chi-Yeon Lim; Su-In Cho
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

5.  Anti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell.

Authors:  Bo Yoon Choi; Jong Cheon Joo; Yeon Kyu Lee; Ik-Soon Jang; Soo Jung Park; Yoon Jung Park
Journal:  BMC Complement Altern Med       Date:  2017-05-25       Impact factor: 3.659

6.  Proteome profiling of lipopolysaccharide induced L6 rat skeletal muscle cells response to flavonoids from Scutellaria baicalensis Georgi.

Authors:  Jin A Kim; Arulkumar Nagappan; Hyeon Soo Park; Venu Venkatarame Gowda Saralamma; Gyeong Eun Hong; Silvia Yumnam; Ho Jeong Lee; Suchismita Raha; Eun Hee Kim; Paik Soon Young; Gon Sup Kim
Journal:  BMC Complement Altern Med       Date:  2014-10-07       Impact factor: 3.659

Review 7.  Chemical Authentication of Botanical Ingredients: A Review of Commercial Herbal Products.

Authors:  Mihael Cristin Ichim; Anthony Booker
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.